Menu Search
Equities

NU Skin Enterprises Inc

NUS:NYQ

NU Skin Enterprises Inc

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)7.32
  • Today's Change0.11 / 1.53%
  • Shares traded1.30m
  • 1 Year change-69.07%
  • Beta1.1393
Data delayed at least 15 minutes, as of Sep 19 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform0
Hold3
Sell0
Strong Sell0

Share price forecast in USD

The 3 analysts offering 12 month price targets for Nu Skin Enterprises, Inc. have a median target of 11.00, with a high estimate of 11.50 and a low estimate of 11.00. The median estimate represents a 50.27% increase from the last price of 7.32.
High57.1%11.50
Med50.3%11.00
Low50.3%11.00

Dividends in USD

In 2023, NU Skin Enterprises Inc reported a dividend of 1.56 USD, which represents a 1.30% increase over last year. The 2 analysts covering the company expect dividends of 0.24 USD for the upcoming fiscal year, a decrease of 84.62%.
Div growth (TTM)1.30%
More ▼

Earnings history & estimates in USD

On Aug 08, 2024, Nu Skin Enterprises, Inc. reported 2nd quarter 2024 earnings of 0.21 per share. This result exceeded the 0.17 consensus of the 3 analysts covering the company and under-performed last year's 2nd quarter results by 61.11%.
The next earnings announcement is expected on Oct 30, 2024.
Average growth rate+6.86%
Nu Skin Enterprises, Inc. reported annual 2023 earnings of 1.85 per share on Feb 14, 2024.
Average growth rate-8.75%
More ▼

Revenue history & estimates in USD

Nu Skin Enterprises, Inc. had 2nd quarter 2024 revenues of 439.08m. This bettered the 431.87m consensus of the 3 analysts covering the company. This was 8.80% below the prior year's 2nd quarter results.
Average growth rate-2.93%
Nu Skin Enterprises, Inc. had revenues for the full year 2023 of 1.97bn. This was 11.53% below the prior year's results.
Average growth rate-4.47%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.